Clinical Trial Update: Senicapoc and Perampanel for Newly Diagnosed Glioblastoma [EARLY_Phase 1]

View source ↗

Summary

This clinical trial update reports a Phase 1 study of combining senicapoc and perampanel for newly diagnosed glioblastoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Fycompa (perampanel)
• Senicapoc (senicapoc)

Snippet

Sponsor: Aarhus University Hospital | Conditions: Glioblastoma | EARLY_Phase 1 | Status: RECRUITING